Kobayashi Pharmaceutical Co., Ltd. increased sales and profits due to strong overseas sales in the second quarter of the fiscal year ending December 2021

 Kobayashi Pharmaceutical's financial results for the second quarter of the fiscal year ending December 2021 were a reaction to the refraining from going out due to the re-expansion of corona infection and the reaction of last year's special demand for sterilization and hygiene-related products, while the international business centered on the United States and China. Sales were strong, and sales and profits increased.

Sales increased 1.3% year-on-year to 67,052 million yen, operating income increased 0.2% to 10,240 million yen, ordinary income increased 0.6% to 11,091 million yen, and net income decreased 4.1%. It was 7,881 million yen.

Comments

Popular posts from this blog

"THE SONOKO White Mask" for moisturizing and transparent skin of adults

Saishunkan Pharmaceutical Co., Ltd. develops overseas business as a major pillar

[Popular "Micho" in Korea] What is the effect and how to drink? I will explain the power of vinegar that is good for beauty!